Effect of vitamin E and pentoxifylline on glycerol-induced acute renal failure

Nephron

Volumn 84, Issue 3, 2000, Pages 243-247

  Akpolat, Tekin ^a,b   Akpolat, Ilkser ^a   Öztürk, Hamit ^a   Sarikaya, Şaban ^a   Coşar, Arif Mansur ^a   Bedir, Abdülkerim ^a   Kandemir, Bedri ^a  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Acute renal failure; Glycerol; Pentoxifylline; Vitamin e

Indexed keywords

ALBIFYLLINE; ALPHA TOCOPHEROL; CISPLATIN; CREATINE KINASE; CREATININE; CYCLOSPORIN A; GLYCEROL; NITROGEN; PENTOXIFYLLINE; SODIUM CHLORIDE; TRENTILIN; UNCLASSIFIED DRUG; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; HISTOLOGY; KIDNEY TUBULE NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 0034092007     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045584     Document Type: Article

References (30)

1. Finn WF: Diagnosis and management of acute tubular necrosis. Med Clin North Am 1990;74: 873-891.
2. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996;334:1448-1460.
3. Brady HR, Singer GG: Acute renal failure. Lancet 1995;346:1533-1540.
4. Mindel JA, Chertow GM: A practical approach to acute renal failure. Med Clin North Am 1997;81:731-748.
5. Houghton DC, Plamp CE, De Fehr JM, Bennett WM, Porter G, Gilbert D: Gentamicin and tobramycin nephrotoxicity. Am J Pathol 1978; 93:137-152.
6. Baliga R, Ueda N, Walker PD, Shah SV: Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997;29:465-477.
7. Zager RA: Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin Nephrol 1997;17:3-14.
8. Vadiei K, Brunner LJ, Luke DR: Effects of pentoxifylline in experimental acute renal failure. Kidney Int 1989;36:466-470.
9. Meydani M: Vitamin E. Lancet 1995;345:170-175.
10. Parra T, de Arriba G, Arribas I, Perez de Lema G, Rodriguez-Puyol D, Rodriguez-Puyol M: Cyclosporine A nephrotoxicity: Role of thromboxane and reactive oxygen species. J Lab Clin Med 1998;131:63-70.
11. Wang C, Salahudeen AK, McClain M, Whitehead J: Lipid pcroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int 1995;47:927-934.
12. Zurovsky Y, Eligal Z, Grossman S: Unilateral renal ischemia reperfusion in the rat: Effect of blood volume trapped in the kidney, sucrose infusion, and antioxidant treatments. Exp Toxicol Pathol 1995;47:471-478.
13. Zurovsky Y, Haber C: Antioxidants attenuate endotoxin-gentamicin induced acute renal failure in rats. Scand J Urol Nephrol 1995;29:147-154.
14. Ademuyiwa O, Ngaha EO, Ubah FO: Vitamin E and selenium in gentamicin nephrotoxicity. Hum Exp Toxicol 1990;9:281-288.
15. Kavutçu A, Canbolat O, Öztürk S, Olcay E, Ulutepe S, Ekinei C, Gökhun IH, Durak I: Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: Effects of vitamins E and C. Nephron 1996;72:269-274.
16. Ramsammy LS, Josepovitz C, Ling K-Y, Lane BP, Kaloyanides GJ: Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat. Biochem Pharmacol 1987;36:2125-2132.
17. Nagano N, Yagi M, Nishikori K: Protective effects of antioxidants on paraquat-induced acute renal failure in mice. Jpn J Pharmacol 1992;59:481-483.
18. 2 by the kidney in glycerol-induced acute renal failure in the rabbit. Prostaglandins 1980;19:333-347.
19. Papanicolaou N, Hatziantoniou C, Dontas A, Gkikas EL, Paris M, Gkikas G, Bariety J: Is thromboxane a potent antinatriuretic factor and is it involved in the development of acute renal failure? Nephron 1987;45:277-282.
20. 2) by pentoxifylline from human vascular tissue. Arzneimittelforschung 1982;32:1315-1218.
21. Kalhs P, Lechner K, Stockschladr M, Krüger W, Peters S, Zander A: Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients. Blood 1992;80:2683-2691.
22. Luke DR, Berens KL, Verani RR: Benefit of vascular decongestion in glycerol-induced acute renal failure. Ren Fail 1991;13:61-69.
23. Boldt J, Müller M, Heesen M, Martin K, Hempelmann G: The effects of pentoxifylline on circulating adhesion molecules in critically ill patients with acute renal failure treated by continuous veno-venous hemofiltration. Intensive Care Med 1996;22:305-311.
24. White JR Jr, Rockwood T, Wilson D, Bettesworth L. Icenogle T: The effects of pentoxifylline on the prevention of cyclosporine-induced nephrotoxicity in cardiac transplant patients. Clin Ther 1994;16:673-679.
25. Luke DR, Vadiei K, Lopez-Berestein G: Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 1992;7:1-7.
26. Bianco JA, Appelbaum FR, Nemunaitis J, Almgren J, Andrews F, Kettner P, Shields A, Singer JW: Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicitics following hone marrow transplantation. Blood 1991;78:1205-1211.
27. Berens KL, Langston JD, Wasan KM, Luke DR: Influence of pentoxifylline and related analogues in endotoxemic renal failure. Circ Shock 1991;34:344-348.
28. Brunner LJ. Vadiei K, Iyer LV, Luke DR: Prevention of cyclosporine-induced nephrotoxicity with pentoxifylline. Ren Fail 1989;11:97-104.
29. Luke DR, Berens KL, Verani RR: Role of vascular decongestion in ischemic acute renal failure defined by postinsult administration of pentoxifylline. Ren Fail 1990;11:187-194.
30. Vadiei K, Tucker SD, Lopez-Berestein G, Wasan KM: Nephroprotective mechanism(s) of pentoxifylline: Reduction of erythrocyte-mediated vascular congestion and inhibition of nitric oxide release. Pharmacol Toxicol 1996; 78:174-180.